Autolus Therapeutics plc Ratios

Ratios Sep2016 Sep2017 Sep2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin -12.52%
EBT Margin -1,182.10%-1,380.98%-3,698.01%-4,780.19%-11,286.97%-9,425.22%-2,398.56%-12,273.38%-2,165.36%
EBIT Margin -1,182.10%-1,383.23%-4,089.05%-5,022.83%-11,415.14%-9,359.65%-2,315.27%-10,583.10%-2,385.63%
EBITDA Margin -1,278.22%-1,117.84%-3,612.08%-4,025.17%-9,454.45%-9,608.83%-2,892.59%-11,688.87%-2,182.25%
Operating Margin -1,383.23%-4,089.05%-5,022.83%-11,415.14%-9,359.65%-2,315.27%-10,583.10%-2,385.63%
Net Margin -1,035.48%-1,162.43%-3,179.18%-4,257.50%-9,644.06%-9,431.85%-2,403.41%-12,272.26%-2,180.45%
FCF Margin -965.68%-1,136.21%-2,889.55%-630.71%-8,991.11%-8,408.63%-1,988.20%-9,221.02%-2,256.38%
Efficiency
Assets Average 210.93M288.37M298.88M349.90M447.92M432.83M579.05M
Equity Average 255.15M232.44M261.68M306.00M205.07M269.40M
Invested Capital 30.69M255.47M254.84M210.03M313.32M298.67M111.47M427.32M
Asset Utilization Ratio 0.010.010.000.000.010.000.02
Leverage & Solvency
Interest Coverage Ratio -127.65-16.10-3.99-25.98
Debt to Equity 0.000.000.00
Debt Ratio 0.010.000.000.00
Equity Ratio 0.940.840.710.770.610.300.55
Times Interest Earned -127.65-16.10-3.99-25.98
Valuation
Enterprise Value -28.06M-137.07M911.48M382.34M313.47M67.77M-209.61M1,421.70M37.36M
Market Capitalization 1,158.56M593.77M467.55M378.45M173.15M1,662.04M625.39M
Return Ratios
Return on Sales -10.35%-11.62%-31.79%-42.57%-96.44%-94.32%-24.03%-122.72%-21.80%
Return on Capital Employed -0.30%-0.55%-0.63%-0.44%-0.36%-0.46%-0.47%
Return on Invested Capital -0.51%-0.62%-0.88%
Return on Assets -0.21%-0.43%-0.48%-0.41%-0.33%-0.48%-0.38%
Return on Equity -0.49%-0.61%-0.54%-0.49%-1.02%-0.82%